Russia’s RDIF sovereign wealth fund said on Tuesday that Mongolia had approved its Sputnik vaccine against COVID-19 for domestic use, becoming the 23rd country to do so globally.

Mongolia granted the vaccine an emergency use authorization without conducting its own clinical trials. The pharmaceutical firm of Mongol Emimpex Concern LLC supported the process, the RussianDirect Investment Fund (RDIF) said in a statement.